SightLife and Ocular Systems Inc. have announced that they will merge their companies into one entity in order achieve their shared goal of eliminating corneal blindness in the U.S. and around the globe, according to a press release.
The combined organization will constitute the largest provider of corneal tissue for transplant in the world, the release said.
The new organization will work to improve corneal surgery for physicians and their patients by working to advance new technology and ophthalmic products. OSI distributes the EndoSerter and EndoSaver corneal endothelium delivery devices used to place corneal endothelial allografts into the eye during specialized transplant procedures. SightLife helped develop the methodology to precisely cut corneal tissue using IntraLase enabled keratoplasty, according to the release.
Services to customers of both companies will continue uninterrupted and to the same quality as before the merger, the release said.